Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margit Rosner

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Stem Cell Research & Therapy|June 20, 2021
Embryoid research calls for reassessment of legal regulationsMarkus Hengstschläger, Margit Rosner
The New England Journal of Medicine|November 2, 2012
Targeting epigenetic readers in cancerMargit Rosner, Markus Hengstschläger
Developmental Cell|April 5, 2024
Oct4 controls basement membrane development during human embryogenesisMargit Rosner, Markus Hengstschläger
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
Detection of cytoplasmic and nuclear functions of mTOR by fractionationMargit Rosner, Markus Hengstschläger
Amino Acids|October 1, 2013
Intercellular protein expression variability as a feature of stem cell pluripotencyMargit Rosner, Markus Hengstschläger
Cell Cycle (Georgetown, Tex.)|January 21, 2012
Spatial consequences of blocking mTOR/S6K: relevance for therapyMargit Rosner, Katharina Schipany, Markus Hengstschläger
Mutation Research. Reviews in Mutation Research|December 11, 2021
Fetomaternal microchimerism and genetic diagnosis: On the origins of fetal cells and cell-free fetal DNA in the pregnant womanMargit Rosner, Thomas Kolbe, Markus Hengstschläger
Amino Acids|December 21, 2012
Phosphorylation of nuclear and cytoplasmic pools of ribosomal protein S6 during cell cycle progressionMargit Rosner, Katharina Schipany, Markus Hengstschläger
Stem Cells Translational Medicine|April 3, 2014
The decision on the "optimal" human pluripotent stem cellMargit Rosner, Katharina Schipany, Markus Hengstschläger
Mutation Research|May 23, 2006
The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27Margit Rosner, Angelika Freilinger, Markus Hengstschläger
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Stem Cell Research & Therapy|June 20, 2021
Embryoid research calls for reassessment of legal regulationsMarkus Hengstschläger, Margit Rosner
The New England Journal of Medicine|November 2, 2012
Targeting epigenetic readers in cancerMargit Rosner, Markus Hengstschläger
Developmental Cell|April 5, 2024
Oct4 controls basement membrane development during human embryogenesisMargit Rosner, Markus Hengstschläger
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
Detection of cytoplasmic and nuclear functions of mTOR by fractionationMargit Rosner, Markus Hengstschläger
Amino Acids|October 1, 2013
Intercellular protein expression variability as a feature of stem cell pluripotencyMargit Rosner, Markus Hengstschläger
Cell Cycle (Georgetown, Tex.)|January 21, 2012
Spatial consequences of blocking mTOR/S6K: relevance for therapyMargit Rosner, Katharina Schipany, Markus Hengstschläger
Mutation Research. Reviews in Mutation Research|December 11, 2021
Fetomaternal microchimerism and genetic diagnosis: On the origins of fetal cells and cell-free fetal DNA in the pregnant womanMargit Rosner, Thomas Kolbe, Markus Hengstschläger
Amino Acids|December 21, 2012
Phosphorylation of nuclear and cytoplasmic pools of ribosomal protein S6 during cell cycle progressionMargit Rosner, Katharina Schipany, Markus Hengstschläger
Stem Cells Translational Medicine|April 3, 2014
The decision on the "optimal" human pluripotent stem cellMargit Rosner, Katharina Schipany, Markus Hengstschläger
Mutation Research|May 23, 2006
The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27Margit Rosner, Angelika Freilinger, Markus Hengstschläger
Pageof 8